Placental Extracellular MatrixInnovaMatrix® AC is the first-ever placental-derived medical device cleared by the FDA for wound management. (wound care treatment)

Discover InnovaMatrix® AC, an innovative solution for managing acute, traumatic, and hard-to-heal wounds. Developed through our exclusive TriCleanse™ Placental Extracellular Matrix (ECM) Process, InnovaMatrix® AC harnesses the natural benefits of placental tissue1,2. It combines these advantages with rigorous quality control, reliability, and a proven safety profile as a medical device3,4.

Our proprietary TriCleanse™ Placental ECM Process achieves thorough tissue decellularization while preserving the ECM's native structure and functionality. This results in a pristine matrix ideal for efficient wound management.

InnovaMatrix® AC is designed for a variety of wound types, including:

• Partial and full-thickness wounds

• Pressure ulcers

• Venous ulcers

• Diabetic ulcers

• Chronic vascular ulcers

• Tunneled/undermined wounds

• Surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence)

• Trauma wounds (abrasions, lacerations, and skin tears)

• Partial-thickness second degree burns

• Draining wounds

For a comprehensive list of indications, please refer to the package insert. InnovaMatrix® AC is intended for single-use only.

Contraindications include sensitivity or allergy to porcine materials or collagen, as well as active or latent infections at or near the application site. This device is not suitable for third degree burns.

InnovaMatrix® AC sets a new standard in wound care, offering advanced healing potential backed by scientific innovation and safety assurance.

( wound care treatment )